DRK for Clinical Trials
Highly experienced team with national, international qualifications & experiences.
Efficient IT structure and large databases powered
Geographical location of DRK is ideal for effective management of clinical trial sites.
Access to investigators’ sites with foreign qualified investigators from the US & UK and ICH-GCP trained
an emerging market for Clinical Trials
Over 220 million population with large number of treatment naive patients
Successful global drug approvals by U.S. FDA & EU EMA based on Phase II & Phase III clinical trials data from the country
Predictable regulatory environment and a government supportive of clinical trials